Pyrenebutyl-methylphosphonofluoridate: A fluorescent anti-cholinesterase in vivo

0Citations
Citations of this article
2Readers
Mendeley users who have this article in their library.
Get full text

Abstract

In vivo properties of pyrenebutyl-methylphosphonofluoridate (PBMPF) have been studied. The LD50 (i.v.) for mice was 15 mg/kg and toxic symptoms were typical of cholinesterase (ChE) inhibition but central signs were absent. After intraventricular injection of PBPMPF in unanaesthetized rabbits, continued walking in bizarre circular fashion together with peripheral vascular dilation and tachypnoea were observed. Recovery occurred 3 h post-injection. Fluorescent particles of anabsorbed material juxtaposed on lining ependyma were observed up to 14 days of administration. In addition, a large number of hippocampal cells showed vivid fluorescence, particularly in the cytoplasm, which was attributed to ChE inhibition. It is concluded that PBMPF seems promising as an organophosphate marker of nerve cells.

Cite

CITATION STYLE

APA

Edery, H. (1983). Pyrenebutyl-methylphosphonofluoridate: A fluorescent anti-cholinesterase in vivo. Archives of Toxicology, 53(Suppl. 6), 327–332. https://doi.org/10.1007/978-3-642-69083-9_61

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Save time finding and organizing research with Mendeley

Sign up for free